Evidence map›Paper›PMID 41279883›Full record

ArticlebioRxiv : the preprint server for biology2025

Tryptoline Stereoprobe Elaboration Identifies Inhibitors of the GRPEL1-HSPA9 Chaperone Complex.

Rachel E Hayward, Raymond F Berkeley, Zijian Gao, Maximilian Garhammer, Marc A Morizono, Evert Njomen, Haoxin Li, Kristen E DeMeester, Victor Cociorva, Mark A Herzik and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rachel E HaywardDepartment of Chemistry, Scripps Research, La Jolla, CA, USA.
Raymond F BerkeleyDepartment of Chemistry, Scripps Research, La Jolla, CA, USA.
Zijian GaoDepartment of Chemistry, University of Oxford, Oxford, UK.
Maximilian GarhammerDepartment of Cellular Biochemistry, Max Planck Institute of Biochemistry, Martinsried, Germany.
Marc A MorizonoDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, USA.
Evert NjomenDepartment of Chemistry, Scripps Research, La Jolla, CA, USA.
Haoxin LiDepartment of Chemistry, Scripps Research, La Jolla, CA, USA.
Kristen E DeMeesterDepartment of Chemistry, Scripps Research, La Jolla, CA, USA.
Victor CociorvaDepartment of Chemistry, Scripps Research, La Jolla, CA, USA.
Mark A HerzikDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, USA.
F Ulrich HartlDepartment of Cellular Biochemistry, Max Planck Institute of Biochemistry, Martinsried, Germany.
Bruno MelilloDepartment of Chemistry, Scripps Research, La Jolla, CA, USA.
Benjamin F CravattDepartment of Chemistry, Scripps Research, La Jolla, CA, USA.

Funding

Chemical Proteomic Platforms for Radically Expanding Cancer DruggabilityR35CA231991 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI BENJAMIN F CRAVATT · 2018 to 2026
$9.5M
MOLECULAR BIOPHYSICS TRAINING PROGRAMT32GM008326 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KOMIVES, ELIZABETH A. · 1989 to 2020
$7.5M
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
Towards an Atomistic Understanding of Mitochondrial Protein Biogenesis (Equipment Supplement)R35GM138206 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HERZIK, MARK ANTHONY · 2020 to 2024
$2.1M
Discovering and Characterizing Druggable Cysteines in Cancer Dependency ProteinsK99CA290143 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI LI, HAOXIN · 2024 to 2025
$332k
NCI NIH HHS K99 CA290143NCI NIH HHS R35 CA231991NIGMS NIH HHS R01 GM129325NIGMS NIH HHS R35 GM138206NIGMS NIH HHS T32 GM008326
6 · The paper itself

Abstract

Activity-based protein profiling has identified hundreds of proteins from diverse classes that react at specific cysteine residues with stereochemically defined electrophilic compounds (stereoprobes) in human cells. The structure-activity relationships underlying these stereoprobe-protein interactions, however, remain poorly understood. Here we show that the protein interaction landscape of tryptoline acrylamide stereoprobes can be profoundly altered by structural modifications distal to the acrylamide reactive group. The majority of stereoprobe liganding events occurred at non-orthosteric sites and mostly evaded assignment by the machine learning-based co-folding model Boltz-2, which instead tended to misplace the stereoprobes in orthosteric pockets (an outcome we term "orthostery burnout"). We found that stereoprobes reacting with C124 in the nucleotide exchange factor GRPEL1 disrupt interactions with the mitochondrial HSP70 chaperone HSPA9/mortalin, leading to impairments in mitochondrial protein import and induction of mitophagy. Our results highlight tryptoline acrylamides as a versatile source of covalent ligands targeting non-orthosteric sites on proteins, including tool compounds that perturb the mitochondrial HSP70 chaperone system.

Identifiers

PMID41279883
PMCPMC12633251

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.